Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Publisher Name :
Date: 9-Nov-2012
No. of pages: 221
Inquire Before Buying

GBI Research’s report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations’ (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% in 2011.

The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic market dominated the market with 82.7% of global APIs revenues.

However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market in both developed and developing economies.

Scope

  • Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.
  • API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain.
  • API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology globally.
  • Drivers and restraints for the global APIs market.
  • Detailed historical, forecast trend and share analysis of API revenues based on product types (synthetic and biotechnology APIs) at the global, regional and key country levels.
  • Detailed historical and forecast trends and share analysis for API revenues based on the customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the global, regional and key country levels.
  • Analysis of API revenues based on therapeutic categories at a global and regional level.

Reasons to buy

  • Develop business strategies with the help with specific insights in the global API market.
  • Identify opportunities and challenges in the global API market.
  • Invest in the growing segments of the APIs market.
  • Increase future revenue and profitability with the help of insights into the future opportunities and critical success factors in the global APIs market.
  • Benchmark your operations and strategies against the major players in the global APIs market.

Active Pharmaceutical Ingredients (API) Global Market to 2017 – Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Table of Contents

1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 12

2 Introduction 15

3 Global Active Pharmaceutical Ingredients Market 16
3.1 Global API Market Overview 16
3.2 Global API Market Drivers 16
3.2.1 Patent Expiries to Change the Dynamics of the Global API Market 16
3.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues 16
3.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth 16
3.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets 16
3.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated Markets 17
3.3 Global API Market Restraints 17
3.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry 17
3.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential 17
3.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market 17
3.3.4 Regulatory Changes to Delay the Launch of New Drugs 18
3.4 Global API Market Revenue Analysis and Forecast to 2017 19
3.4.1 Global API Market Revenue Share by Product Type 21
3.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017 22
3.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base 26
3.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017 27
3.5 Global Biotech Market Analysis 29
3.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017 29
3.6 Global Biotech Market Revenue Analysis by Customer Base 34
3.6.1 Global Biotech Market Revenue Share Analysis by Customer Base 34
3.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017 35
3.7 Global Contract Manufacturing Organizations 37
3.7.1 Global CMO Outsourcing Process 38
3.7.2 Global CMO Market Drivers 39
3.7.3 Global CMO Market Outsourcing Benefits 40
3.7.4 Global CMO Market Revenues and Forecast to 2017 41

4 North America Active Pharmaceutical Ingredients Market 43
4.1 North America API Market Overview 43
4.2 North America API Market Drivers 43
4.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America 43
4.2.2 Generic Sector Supports the Growth of the North American API Market 43
4.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth 43
4.3 North American API Market Restraints 44
4.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth 44
4.3.2 High Cost of New Drug Development Hampers Innovation 44
4.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America 44
4.4 North America API Market Revenue Analysis and Forecast to 2017 45
4.5 North America API Market Revenue Share Analysis by Product Type 47
4.6 North America Synthetic Market Analysis 48
4.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017 48
4.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base 53
4.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 54
4.7 North America Biotech Market Analysis 56
4.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017 56
4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 61
4.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 62
4.8 North America API Market Revenue Share Analysis by Therapeutic Applications 64
4.9 The US Active Pharmaceutical Ingredients Market 65
4.9.1 The US API Market Overview 65
4.9.2 The US API Market Revenue by Product Type and Forecast to 2017 66
4.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 68
4.9.4 The US API Market by Customer Base 69
4.10 Canada Active Pharmaceutical Ingredients Market 75
4.10.1 Canada API Market Overview 75
4.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017 75
4.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 77
4.10.4 Canada API Market by Customer Base 78

5 Asia-Pacific Active Pharmaceutical Ingredients Market 84
5.1 Asia-Pacific API Market Overview 84
5.2 Asia-Pacific APIs Market Drivers 85
5.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture 85
5.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth 85
5.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth 85
5.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs 85
5.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets 85
5.3 Asia-Pacific API Market Restraints 86
5.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market 86
5.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market 86
5.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential 86
5.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region 86
5.4 Asia-Pacific API Market Revenue and Forecasts to 2017 87
5.5 Asia-Pacific Revenue Share Analysis by Product Type 89
5.6 Asia-Pacific Synthetic Market 90
5.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 90
5.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 95
5.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 96
5.7 Asia-Pacific Biotech Market 98
5.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 98
5.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 104
5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 105
5.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications 107
5.9 Japan Active Pharmaceutical Ingredients Market 108
5.9.1 Japan API Market Overview 108
5.9.2 Japan API Market Revenues and Forecasts to 2017 108
5.9.3 Japan API Market Revenue Share Analysis by Product Type 110
5.9.4 Japan API Market by Customer Base 111
5.10 China Active Pharmaceutical Ingredients Market 117
5.10.1 China API Market Overview 117
5.10.2 China API Market Revenues by Product Type and Forecasts to 2017 118
5.10.3 China API Market Revenue Share Analysis by Product Types 120
5.10.4 China API Market by Customer Base 121
5.11 South Korea Active Pharmaceutical Ingredients Market 127
5.11.1 South Korea API Market Overview 127
5.11.2 South Korea APIs Market Revenue and Forecasts to 2017 128
5.11.3 South Korea API Market Revenue Share Analysis by Product Type 130
5.11.4 South Korea API Market by Customer Base 131
5.12 India Active Pharmaceutical Ingredients Market 137
5.12.1 India API Market Overview 137
5.12.2 India API Market Revenue and Forecasts to 2017 138
5.12.3 India API Market Revenue Share Analysis by Product Types 140
5.12.4 India API Market by Customer Base 141

6 Europe Active Pharmaceutical Ingredients Market 147
6.1 Europe API Market Overview 147
6.2 Europe API Market Drivers 147
6.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe 147
6.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market 147
6.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe 147
6.2.4 European Regulatory Framework to Facilitate Development of Biosimilars 147
6.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe 147
6.3 Europe API Market Restraints 148
6.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products 148
6.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market 148
6.3.3 Price Cuts to Restrict Revenue Growth for the European API Market 149
6.4 Europe API Market Revenue Analysis and Forecast to 2017 151
6.5 Europe API Market Revenue Share Analysis by Product Type 153
6.6 Europe Synthetic Market Analysis 154
6.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017 154
6.6.2 European Synthetic Market Revenue Share Analysis by Customer Base 159
6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 160
6.7 Europe Biotech Market Analysis 162
6.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017 162
6.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base 167
6.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017 168
6.8 Europe API Market Revenue Share Analysis by Therapeutic Applications 170
6.9 Germany Active Pharmaceutical Ingredients Market 172
6.9.1 Germany API Market Overview 172
6.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017 172
6.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 174
6.9.4 Germany API Market by Customer Base 175
6.10 France Active Pharmaceutical Ingredients Market 181
6.10.1 France API Market Overview 181
6.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017 181
6.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017 183
6.10.4 France API Market by Customer Base 184
6.11 Italy Active Pharmaceutical Ingredients Market 190
6.11.1 Italy API Market Overview 190
6.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017 190
6.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 192
6.11.4 Italy API Market by Customer Base 193
6.12 The UK Active Pharmaceutical Ingredients Market 199
6.12.1 The UK API Market Overview 199
6.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017 199
6.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 201
6.12.4 The UK API Market by Customer Base 202
6.13 Spain Active Pharmaceutical Ingredients Market 208
6.13.1 Spain API Market Overview 208
6.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017 208
6.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 210
6.13.4 Spain API Market by Customer Base 211

7 Appendix 217
7.1 Abbreviations 217
7.2 Bibliography 218
7.3 Market Definitions 219
7.4 Methodology 219
7.4.1 Coverage 219
7.4.2 Secondary Research 220
7.4.3 Primary Research 220
7.4.4 Expert Panel Validation 220
7.5 Contact Us 221
7.6 Disclaimer 221

List of Tables

Table 1: API Market, Global, Total Revenue Analysis, $m, 2005-2017 20
Table 2: API Market, Global, Revenue Share by Product Types, %, 2011 21
Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005-2017 23
Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011 24
Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005-2017 25
Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011 26
Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005-2017 28
Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005-2017 30
Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011 31
Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005-2017 33
Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011 34
Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005-2017 36
Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011 39
Table 14: CMO Market, Global, Market Revenues, $m, 2005-2017 42
Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012-2016 44
Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005-2017 46
Table 17: API Market, North America, Revenue Share by Product Type, %, 2005-2017 47
Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005-2017 49
Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %, 2011 50
Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005-2017 52
Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011 53
Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005-2017 55
Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005-2017 57
Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011 58
Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005-2017 60
Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 2011 61
Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005-2017 63
Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011-2017 65
Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005-2017 67
Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005-2017 68
Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005-2017 70
Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005-2017 71
Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005-2017 73
Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005-2017 74
Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005-2017 76
Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005-2017 77
Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005-2017 79
Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005-2017 80
Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005-2017 82
Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005-2017 83
Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005-2017 88
Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011 89
Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005-2017 91
Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 92
Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005-2017 95
Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011 95
Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005-2017 97
Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005-2017 99
Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 100
Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017 103
Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011 104
Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005-2017 106
Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011-2017 107
Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005-2017 109
Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005-2017 110
Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005-2017 112
Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005-2017 113
Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005-2017 115
Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005-2017 116
Table 60: API Market, China, Market Revenues by Product Type, $m, 2005-2017 119
Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005-2017 120
Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005-2017 122
Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017 123
Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005-2017 125
Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005-2017 126
Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005-2017 129
Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005-2017 130
Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017 132
Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005-2017 133
Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005-2017 135
Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005-2017 136
Table 72: API Market, India, Market Revenues by Product Types, $m, 2005-2017 139
Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005-2017 140
Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005-2017 142
Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005-2017 143
Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005-2017 145
Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005-2017 146
Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and Reimbursement Mechanism, 2011 149
Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005-2017 152
Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011 153
Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005-2017 155
Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011 156
Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005-2017 158
Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011 159
Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005-2017 161
Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005-2017 163
Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011 164
Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005-2017 166
Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011 167
Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005-2017 169
Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011-2017 171
Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005-2017 173
Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005-2017 174
Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005-2017 176
Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005-2017 177
Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005-2017 179
Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005-2017 180
Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005-2017 182
Table 99: API Market, France, Revenue Share by Product Type, %, 2005-2017 183
Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005-2017 185
Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005-2017 186
Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005-2017 188
Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005-2017 189
Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005-2017 191
Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005-2017 192
Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005-2017 194
Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005-2017 195
Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005-2017 197
Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005-2017 198
Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005-2017 200
Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005-2017 201
Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005-2017 203
Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005-2017 204
Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005-2017 206
Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005-2017 207
Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005-2017 209
Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005-2017 210
Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005-2017 212
Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005-2017 213
Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005-2017 215
Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005-2017 216

List of Figures

Figure 1: API Market, Global, Total Revenue Analysis ($m), 2005-2017 19
Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011 21
Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005-2017 22
Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011 24
Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005-2017 25
Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011 26
Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005-2017 27
Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005-2017 29
Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011 31
Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005-2017 32
Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011 34
Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005-2017 35
Figure 13: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project 38
Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011 39
Figure 15: CMO Market Key Benefits of Outsourcing to CMOs 40
Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017 41
Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005-2017 45
Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005-2017 47
Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005-2017 48
Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011 50
Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%), 2005-2017 51
Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%), 2005-2017 52
Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011 53
Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m), 2005-2017 54
Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005-2017 56
Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011 58
Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%), 2005-2017 59
Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005-2017 60
Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 2011 61
Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005-2017 62
Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011-2017 64
Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005-2017 66
Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005-2017 68
Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005-2017 69
Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005-2017 71
Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005-2017 72
Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005-2017 74
Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005-2017 75
Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005-2017 77
Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005-2017 78
Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005-2017 80
Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005-2017 81
Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005-2017 83
Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005-2017 87
Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011 89
Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005-2017 90
Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 92
Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005-2017 93
Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005-2017 94
Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011 95
Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m), 2005-2017 96
Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005-2017 98
Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 100
Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005-2017 101
Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005-2017 102
Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011 104
Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005-2017 105
Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011-2017 107
Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005-2017 108
Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005-2017 110
Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005-2017 111
Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005-2017 113
Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005-2017 114
Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005-2017 116
Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005-2017 118
Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005-2017 120
Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005-2017 121
Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017 123
Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005-2017 124
Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005-2017 126
Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005-2017 128
Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005-2017 130
Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017 131
Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005-2017 133
Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005-2017 134
Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005-2017 136
Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005-2017 138
Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005-2017 140
Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005-2017 141
Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005-2017 143
Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005-2017 144
Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005-2017 146
Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005-2017 151
Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011 153
Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005-2017 154
Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011 156
Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005-2017 157
Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%), 2005-2017 158
Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011 159
Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005-2017 160
Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005-2017 162
Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011 164
Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005-2017 165
Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005-2017 166
Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011 167
Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005-2017 168
Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011-2017 170
Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005-2017 172
Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005-2017 174
Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005-2017 175
Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005-2017 177
Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005-2017 178
Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005-2017 180
Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005-2017 181
Figure 105: API Market, France, Revenue Share by Product Type (%), 2005-2017 183
Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005-2017 184
Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005-2017 186
Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005-2017 187
Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005-2017 189
Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005-2017 190
Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005-2017 192
Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005-2017 193
Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005-2017 195
Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005-2017 196
Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005-2017 198
Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005-2017 199
Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005-2017 201
Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005-2017 202
Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005-2017 204
Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005-2017 205
Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005-2017 207
Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005-2017 208
Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005-2017 210
Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005-2017 211
Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005-2017 213
Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005-2017 214
Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005-2017 216

  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • 2014 Market Research Report on Global Disposable Syringe Industry
    Published: 17-Dec-2014        Price: US $2600 Onwards        Pages: 178
    This is a professional and depth research report on Global Disposable Syringe industry For overview analysis, the report introduces Disposable Syringe basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Disposable Syringe markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research o......
  • 2014 Market Research Report on Global Vitamin K3 Industry
    Published: 17-Dec-2014        Price: US $2600 Onwards        Pages: 180
    This is a professional and depth research report on Global Vitamin K3 industry For overview analysis, the report introduces Vitamin K3 basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Vitamin K3 markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of dif......
  • Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 84
    BMI View: The World Health Organization's approval of a quality control laboratory for medicines in Zimbabwe is a positive step for the country's pharmaceutical market. It will help to reduce the proportion of counterfeit medicines in circulation and increase the country's attractiveness to multinational drugmakers. Nevertheless, for the foreseeable future the dire economic and political outlook, reduced healthcare budget and underdeveloped local manufacturing industry will continue to limit inv......
  • Global LBS Market in Healthcare Industry 2015-2019
    Published: 17-Dec-2014        Price: US $2500 Onwards        Pages: 95
    LBS is an information service that uses real-time geographical data from a location-enabled device to provide security services, and information. LBS applications are predominantly used in hospitals to improve efficiency and reduce expenditure. It works on Wi-Fi and RTLS technology in indoor location. LBS is used in hospitals for indoor navigation, tracking staff and patients, location-based messaging, asset management, location analytics, and in integrating with other clinical systems. TechN......
  • Bahrain Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 101
    BMI View: Our outlook for Bahrain's pharmaceutical and healthcare sector remains strong, with the government announcing the development and expansion of health centres across the country in addition to several preventive health projects planned. Despite recent price cuts negatively impacting the market in the short term, we believe an ageing population, increasing chronic disease burden and robust economic growth will drive medicine demand for many years to come. Headline Expenditure Projections......
  • Bangladesh Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 112
    BMI View: Chronic diseases will become a key healthcare challenge for Bangladesh over the next decade. Driven by the country's ageing population, urbanisation and inadequate treatment of non-communicable diseases, this represents an epidemiological transition that will present new opportunities for pharmaceutical companies. Headline Expenditure Projections ? Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4% in local currency terms and +11.9% in US dollar......
  • Nurse Call System Market in the US 2015-2019
    Published: 17-Dec-2014        Price: US $2500 Onwards        Pages: 70
    Nurse Call System is a communication solution used in healthcare facilities, which enables patients to alert caregivers in case of any routine need or emergency assistance. It serves as the core component of healthcare communication platform and is an innovative, reliable service that alerts the nursing staff through visual and audio signals. It provides the location of the patient in need and indicates the urgency of the call, regardless of the patient's location in the hospital or care center.......
  • Belarus Pharmaceuticals and Healthcare Report Q1 2015
    Published: 17-Dec-2014        Price: US $1295 Onwards        Pages: 87
    BMI View: The Belarusian market will suffer from the impact of depreciation and economic instability as the country's economy becomes ever more reliant on Russian loans to function. Furthermore, wage growth mandated by the government will become unsustainable, threatening to dampen internal consumption. Belarus will present little reward for high risk for most pharmaceutical companies in the region. Headline Expenditure Projections Pharmaceuticals: BYR8,927bn in 2013 (USD1.00bn) to BYR11,490bn (......
  • Global Rehabilitation Robotics Market 2015-2019
    Published: 17-Dec-2014        Price: US $2500 Onwards        Pages: 50
    Rehabilitation robots play an important role in improving a patient's functional recovery. Stroke is a global problem, and it is the main cause of disability in most western countries. Rehabilitation robots are used as therapy aids and the potential benefit of robotic therapy is that it can treat a larger number of patients under the supervision of a single therapist. In other words, rehabilitation robots work as a therapeutic tool for optimizing and maximizing clinical effectiveness of a therap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs